Shaobo Ke
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 13
- Pancreatic and Hepatic Oncology Research 5
- Cancer Immunotherapy and Biomarkers 4
- Lung Cancer Research Studies 3
- Colorectal Cancer Treatments and Studies 2
-
- Gastric Cancer Management and Outcomes 6
- Co-authors
- Hu Qiu (16 shared papers)Yongshun Chen (15 shared papers)Jiamei Chen (11 shared papers)Wei Shi (3 shared papers)Wensi Zhao (9 shared papers)Yi Gong (2 shared papers)Yongshun Chen (3 shared papers)Lin Wu (2 shared papers)
- Journals
- Radiotherapy and Oncology (3 papers)Cancer Research (1 paper)Gene (1 paper)Chemical and Pharmaceutical Bulletin (1 paper)Targeted Oncology (1 paper)
- Partner nations
- ChinaNetherlandsJapan
In The Last Decade
Shaobo Ke
24 papers receiving 388 citations
Peers
Comparison fields: 5 of 48
- Cancer Research 93
- Oncology 131
- Pulmonary and Respiratory Medicine 126
- Clinical Biochemistry 23
- Molecular Biology 198
Countries citing papers authored by Shaobo Ke
This map shows the geographic impact of Shaobo Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaobo Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaobo Ke more than expected).
Fields of papers citing papers by Shaobo Ke
This network shows the impact of papers produced by Shaobo Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaobo Ke. The network helps show where Shaobo Ke may publish in the future.
Co-authors
The 25 scholars most cited alongside Shaobo Ke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 66 | |
| 2 | 2014 | 52 | |
| 3 | 2019 | 33 | |
| 4 | 2018 | 27 | |
| 5 | 2016 | 25 | |
| 6 | 2019 | 21 | |
| 7 | 2021 | 21 | |
| 8 | 2019 | 19 | |
| 9 | 2023 | 18 | |
| 10 | 2018 | 16 | |
| 11 | 2017 | 16 | |
| 12 | 2023 | 12 | |
| 13 | 2022 | 12 | |
| 14 | 2021 | 9 | |
| 15 | 2018 | 8 | |
| 16 | 2021 | 7 | |
| 17 | 2013 | 6 | |
| 18 | 2022 | 6 | |
| 19 | Clinical considerations for the management of cancer patients in the mitigation stage of the COVID-19 pandemic. | 2020 | 5 |
| 20 | 2021 | 4 |
About Shaobo Ke
Shaobo Ke is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Cancer Research, having authored 24 papers that have together received 390 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (9 papers), Gastric Cancer Management and Outcomes (6 papers), Pancreatic and Hepatic Oncology Research (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Esophageal and GI Pathology (4 papers), Lung Cancer Research Studies (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (93 citations), Oncology (131 citations), Pulmonary and Respiratory Medicine (126 citations), Clinical Biochemistry (23 citations) and Molecular Biology (198 citations). Shaobo Ke has collaborated with scholars based in China, Netherlands and Japan. Frequent co-authors include Hu Qiu, Yongshun Chen, Jiamei Chen, Wei Shi, Wensi Zhao, Yi Gong, Yongshun Chen, Lin Wu, Qiushuang Wang and Wei Shi. Their work appears in journals such as Radiotherapy and Oncology, Cancer Research, Gene, Chemical and Pharmaceutical Bulletin and Targeted Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.